ACELLYTRON THERAPEUTICS Trademark

Trademark Overview


On Friday, March 8, 2024, a trademark application was filed for ACELLYTRON THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ACELLYTRON THERAPEUTICS trademark a serial number of 79406657. The federal status of this trademark filing is REGISTERED as of Tuesday, May 20, 2025. This trademark is owned by Wuxi Biologics (Shanghai) Co., Ltd.. The ACELLYTRON THERAPEUTICS trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Research and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development of services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects

Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance

Chemical-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological ag...

Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
acellytron therapeutics

General Information


Serial Number79406657
Word MarkACELLYTRON THERAPEUTICS
Filing DateFriday, March 8, 2024
Status700 - REGISTERED
Status DateTuesday, May 20, 2025
Registration Number7797742
Registration DateTuesday, May 20, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 1, 2025

Trademark Statements


Goods and ServicesResearch and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development of services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects
Goods and ServicesPreparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance
Goods and ServicesChemical-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely, biological preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor for inhibiting the growth of cancer cells; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely, tumor suppressor; cells for medical use; dietetic infusions, sugar, foods, and beverages substances adapted for medical use; biological preparations for veterinary purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer
Goods and ServicesOnline advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
Description of MarkThe mark consists of the stylized wording "ACELLYTRON THERAPEUTICS" with a double strand DNA inside the stylized letter "O".
NOT AVAILABLETHERAPEUTICS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWuxi Biologics (Shanghai) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCN

Party NameWuxi Biologics (Shanghai) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameWuxi Biologics (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Thursday, October 10, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 16, 2024APPLICATION FILING RECEIPT MAILED
Thursday, October 17, 2024ASSIGNED TO EXAMINER
Thursday, October 24, 2024NON-FINAL ACTION WRITTEN
Friday, October 25, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 30, 2024REFUSAL PROCESSED BY MPU
Wednesday, October 30, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, November 17, 2024REFUSAL PROCESSED BY IB
Tuesday, March 4, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 6, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 1, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 1, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 20, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 20, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, August 21, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, December 19, 2025FINAL DISPOSITION PROCESSED
Friday, December 19, 2025FINAL DISPOSITION NOTICE SENT TO IB